<MedlineCitation Owner="NLM" Status="MEDLINE">
	<PMID>19754890</PMID>
	<DateCreated>
		<Year>2009</Year>
		<Month>09</Month>
		<Day>16</Day>
	</DateCreated>
	<DateCompleted>
		<Year>2009</Year>
		<Month>11</Month>
		<Day>04</Day>
	</DateCompleted>
	<Article PubModel="Print">
		<Journal>
			<ISSN IssnType="Electronic">1600-065X</ISSN>
			<JournalIssue CitedMedium="Internet">
				<Volume>231</Volume>
				<Issue>1</Issue>
				<PubDate>
					<Year>2009</Year>
					<Month>Sep</Month>
				</PubDate>
			</JournalIssue>
			<Title>Immunological reviews</Title>
			<ISOAbbreviation>Immunol. Rev.</ISOAbbreviation>
		</Journal>
		<ArticleTitle>The functional network of ion channels in T lymphocytes.
		</ArticleTitle>
		<Pagination>
			<MedlinePgn>59-87</MedlinePgn>
		</Pagination>
		<Abstract>
			<AbstractText>For more than 25 years, it has been widely appreciated
				that Ca2+ influx is essential to trigger T-lymphocyte activation.
				Patch clamp analysis, molecular identification, and functional
				studies using blockers and genetic manipulation have shown that a
				unique contingent of ion channels orchestrates the initiation,
				intensity, and duration of the Ca2+ signal. Five distinct types of
				ion channels--Kv1.3, KCa3.1, Orai1+ stromal interacting molecule 1
				(STIM1) [Ca2+-release activating Ca2+ (CRAC) channel], TRPM7, and
				Cl(swell)--comprise a network that performs functions vital for
				ongoing cellular homeostasis and for T-cell activation, offering
				potential targets for immunomodulation. Most recently, the roles of
				STIM1 and Orai1 have been revealed in triggering and forming the
				CRAC channel following T-cell receptor engagement. Kv1.3, KCa3.1,
				STIM1, and Orai1 have been found to cluster at the immunological
				synapse following contact with an antigen-presenting cell; we
				discuss how channels at the synapse might function to modulate local
				signaling. Immuno-imaging approaches are beginning to shed light on
				ion channel function in vivo. Importantly, the expression pattern of
				Ca2+ and K+ channels and hence the functional network can adapt
				depending upon the state of differentiation and activation, and this
				allows for different stages of an immune response to be targeted
				specifically.</AbstractText>
		</Abstract>
		<Affiliation>Department of Physiology and Biophysics, and the
			Institute for Immunology, University of California, Irvine, Irvine,
			CA 92697-4561, USA. mcahalan@uci.edu</Affiliation>
		<AuthorList CompleteYN="Y">
			<Author ValidYN="Y">
				<LastName>Cahalan</LastName>
				<ForeName>Michael D</ForeName>
				<Initials>MD</Initials>
			</Author>
			<Author ValidYN="Y">
				<LastName>Chandy</LastName>
				<ForeName>K George</ForeName>
				<Initials>KG</Initials>
			</Author>
		</AuthorList>
		<Language>eng</Language>
		<GrantList CompleteYN="Y">
			<Grant>
				<GrantID>GM-41514</GrantID>
				<Acronym>GM</Acronym>
				<Agency>NIGMS NIH HHS</Agency>
				<Country>United States</Country>
			</Grant>
			<Grant>
				<GrantID>NS-048252</GrantID>
				<Acronym>NS</Acronym>
				<Agency>NINDS NIH HHS</Agency>
				<Country>United States</Country>
			</Grant>
			<Grant>
				<GrantID>NS-14609</GrantID>
				<Acronym>NS</Acronym>
				<Agency>NINDS NIH HHS</Agency>
				<Country>United States</Country>
			</Grant>
		</GrantList>
		<PublicationTypeList>
			<PublicationType>Journal Article</PublicationType>
			<PublicationType>Research Support, N.I.H., Extramural
			</PublicationType>
			<PublicationType>Review</PublicationType>
		</PublicationTypeList>
	</Article>
	<MedlineJournalInfo>
		<Country>Denmark</Country>
		<MedlineTA>Immunol Rev</MedlineTA>
		<NlmUniqueID>7702118</NlmUniqueID>
		<ISSNLinking>0105-2896</ISSNLinking>
	</MedlineJournalInfo>
	<ChemicalList>
		<Chemical>
			<RegistryNumber>0</RegistryNumber>
			<NameOfSubstance>Ion Channels</NameOfSubstance>
		</Chemical>
	</ChemicalList>
	<CitationSubset>IM</CitationSubset>
	<MeshHeadingList>
		<MeshHeading>
			<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
		</MeshHeading>
		<MeshHeading>
			<DescriptorName MajorTopicYN="N">Autoimmune Diseases
			</DescriptorName>
			<QualifierName MajorTopicYN="N">immunology</QualifierName>
			<QualifierName MajorTopicYN="N">metabolism</QualifierName>
			<QualifierName MajorTopicYN="N">therapy</QualifierName>
		</MeshHeading>
		<MeshHeading>
			<DescriptorName MajorTopicYN="N">Calcium Signaling
			</DescriptorName>
		</MeshHeading>
		<MeshHeading>
			<DescriptorName MajorTopicYN="N">Cell Movement
			</DescriptorName>
		</MeshHeading>
		<MeshHeading>
			<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
		</MeshHeading>
		<MeshHeading>
			<DescriptorName MajorTopicYN="N">Ion Channels
			</DescriptorName>
			<QualifierName MajorTopicYN="N">chemistry</QualifierName>
			<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
		</MeshHeading>
		<MeshHeading>
			<DescriptorName MajorTopicYN="N">Lymphocyte Activation
			</DescriptorName>
		</MeshHeading>
		<MeshHeading>
			<DescriptorName MajorTopicYN="N">T-Lymphocytes
			</DescriptorName>
			<QualifierName MajorTopicYN="N">chemistry</QualifierName>
			<QualifierName MajorTopicYN="N">cytology</QualifierName>
			<QualifierName MajorTopicYN="Y">immunology</QualifierName>
			<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
		</MeshHeading>
	</MeshHeadingList>
	<NumberOfReferences>293</NumberOfReferences>
</MedlineCitation>